Plain-English translation of NCT07218510 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a treatment plan using three medications—, , and —for people newly diagnosed with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to see if this combination can eliminate cancer cells so completely that doctors cannot detect any remaining disease. The study is watching whether the treatment works well and is safe for patients to take.
CLL and SLL are blood cancers that need new, more effective treatments. This trial is exploring whether using these three medications together in a specific sequence can help patients achieve deeper and longer-lasting remissions than older treatment approaches.
You likely qualify if…
You likely don't qualify if…
You would visit the cancer center regularly over about one year for up to 12 monthly treatment cycles. The first medication is given through an IV infusion; the second is a daily pill you take at home; the third starts later and is injected under the skin. Throughout the study, you'll have blood tests and imaging scans (CT or MRI) to check how well the treatment is working. Some patients may also have a bone marrow biopsy. If your disease responds well but isn't completely cleared, you may continue with one of the medications for up to six additional months.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States